Erratum: Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent (Gene Therapy (2007) vol. 14 (1175-1180) 10.1038/sj.gt.3302964);Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent

Gene Therapy

Volumn 14, Issue 15, 2007, Pages 1175-1180

  Probst, J ^a,b   Weide, B ^a   Scheel, B ^a,b   Pichler, B J ^a   Hoerr, I ^b   Rammensee, H G ^a   Pascolo, S ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b CureVac GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NUCLEIC ACID; PLASMID DNA; RINGER LACTATE SOLUTION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DERMIS; GOOD MANUFACTURING PRACTICE; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO GENE TRANSFER; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NORMAL HUMAN; PRIORITY JOURNAL; RNA TRANSCRIPTION; RNA TRANSLATION; RNA TRANSPORT; RNA VECTOR;

EID: 34447633941     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2008.175     Document Type: Erratum

References (17)

1. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247: 1465-1468.
2. Robinson HL, Hunt LA, Webster RG. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 1993; 11: 957-960.
3. Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993; 259 1745-1749.
4. Boczkowski D, Nair SK, Snyder D, Gilboa E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 1996; 184: 465-472.
5. Carralot JP, Probst J, Hoerr I, Scheel B, Teufel R, Jung G et al. Polarization of the immunity induced by direct injection of naked globin UTR-stabilized mRNA vaccines. Cell Mol Life Sci 2004; 61: 2418-2424.
6. Conry RM, LoBuglio AF, Wright M, Sumerel L, Pike MJ, Johanning F et al. Characterization of a messenger RNA polynucleotide vaccine vector. Cancer Res 1995; 55: 1397-1400.
7. Granstein RD, Ding W, Ozawa H. Induction of anti-tumor immunity with epidermal cells pulsed with tumor-derived RNA or intradermal administration of RNA. J Invest Dermatol 2000; 114: 632-636.
8. Hoerr I, Obst R, Rammensee HG, Jung G. In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies. Eur J Immunol 2000, 30: 1-7.
9. Pascolo S. Messenger RNA-based vaccines. Expert Opin Biol Ther 2004; 4: 1285-1294.
10. Donnelly J, Berry Y, Ulmer JB. Technical and regulatory hurdles for DNA vaccines. Int J Parasitol 2003; 33: 457-467.
11. Klinman DM, Takeno M, Ichino M, Gu M, Yamshchikov G, Mor G et al. DNA vaccines: Safety and efficacy issues. Springer Semin Immunopathol 1997; 19: 245-256.
12. Forg P, von Hoegen P, Dalemans W, Schirrmacher V. Superiority of the ear pinna over muscle tissue as site for DNA vaccination. Gene Therapy 1998; 5: 789-797.
13. Lyons JC, Ross BD, Song CW. Enhancement of hyperthermia effect in vivo by amiloride and DIDS. Int J Radiat Oncol Biol Phys 1993; 25: 95-103.
14. Messiha FS. Neurotoxicity of chlorpromazine and modulation by amantadine as a function of mouse strain. Neurotoxicology 1991; 12: 571-581.
15. Uma DP, Satish Rao BS, Kamath R. A method to score micronuclei in vivo using cytochalasin B-induced cytokinesis block. Mut Res 1990; 40: 133-37.
16. Mehta RT, Hopfer RL, McQueen T, Juliano RL, Lopez-Berestein G. Toxicity and therapeutic effects in mice of liposome-ecapsulated nystatin for systemic fungal infections. Antimicrob Agents Chemother 1987; 31: 1901-1903.
17. Benner SA. Extracellular 'communicator RNA'. FEBS Lett 1988; 233: 225-228.